BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34994613)

  • 21. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort.
    Karpel H; Manderski E; Pothuri B
    Int J Gynecol Cancer; 2023 Jul; 33(7):1044-1050. PubMed ID: 36889816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing.
    Yu Z; Zhang Z; Liu J; Wu X; Fan X; Pang J; Bao H; Yin J; Wu X; Shao Y; Liu Z; Liu F
    Mol Oncol; 2024 May; 18(5):1301-1315. PubMed ID: 37885353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
    Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
    Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
    Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
    BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
    Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.
    Walter D; Harter PN; Battke F; Winkelmann R; Schneider M; Holzer K; Koch C; Bojunga J; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Waidmann O
    Sci Rep; 2018 Feb; 8(1):3811. PubMed ID: 29491456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
    Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B
    Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in small bowel neuroendocrine neoplasia.
    Banck MS; Beutler AS
    Curr Opin Gastroenterol; 2014 Mar; 30(2):163-7. PubMed ID: 24441281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
    Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
    Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors.
    Sei Y; Feng J; Zhao X; Forbes J; Tang D; Nagashima K; Hanson J; Quezado MM; Hughes MS; Wank SA
    Gastroenterology; 2016 Jul; 151(1):140-51. PubMed ID: 27003604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
    Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
    Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
    Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of Entrectinib in a Patient With the First Reported
    Sigal D; Tartar M; Xavier M; Bao F; Foley P; Luo D; Christiansen J; Hornby Z; Maneval EC; Multani P
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1317-1322. PubMed ID: 29118225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genomic landscape of small intestine neuroendocrine tumors.
    Banck MS; Kanwar R; Kulkarni AA; Boora GK; Metge F; Kipp BR; Zhang L; Thorland EC; Minn KT; Tentu R; Eckloff BW; Wieben ED; Wu Y; Cunningham JM; Nagorney DM; Gilbert JA; Ames MM; Beutler AS
    J Clin Invest; 2013 Jun; 123(6):2502-8. PubMed ID: 23676460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
    Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
    Drozdov I; Svejda B; Gustafsson BI; Mane S; Pfragner R; Kidd M; Modlin IM
    PLoS One; 2011; 6(8):e22457. PubMed ID: 21853033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.